Literature DB >> 4271573

Blastogenic suppression and alloantibody activity of sera from renal allograft recipients.

A H Johnson, R D Rossen, E M Hersh, S S Farrow, W T Butler, W N Suki.   

Abstract

To evaluate whether immunological enhancement plays a role in adaptation to renal allografts, we studied sera from transplant recipients to determine whether those which suppressed mixed leukocyte culture (MLC) responses in vitro contained alloantibodies reactive with donor cells. Sera from five of nine renal transplant recipients consistently and specifically suppressed autologous autologous MLC responses to donor cells without impairing the blastogenic responses to third-party leukocytes, soluble antigens, or nonspecific mitogenic agents. In three of the five cases the suppressive activity of the serum was striking; in two cases the effect was less marked but still readily demonstrable in studies designed to evaluate the dose of serum which provided optimal suppression of MLC responses. Serum from one of the recipients nonspecifically suppressed blastogenic activity both to donor cells and other stimuli. No alloantibody reactive with donor leukocytes was found in any of the sera which exhibited suppressive activity in MLC, whereas in one patient, serum which contained antibody reactive with donor cells did not suppress MLC response to that donor. These findings suggest that, if the serum factors which suppress MLC responses in vitro are enhancing antibodies, they are not detectable even with very sensitive techniques either because they are present in very low concentrations, belong to immunoglobulin classes other than IgA, IgG, or IgM, or are complexed with donor antigen in such a way that their ability to react with fresh donor cells in vitro is blocked.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4271573      PMCID: PMC301462          DOI: 10.1172/JCI107547

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  The human primary immune response to keyhole limpet haemocyanin: interrelationships of delayed hypersensitivity, antibody response and in vitro blast transformation.

Authors:  J E Curtis; E M Hersh; J E Harris; C McBride; E J Freireich
Journal:  Clin Exp Immunol       Date:  1970-04       Impact factor: 4.330

2.  Immunological enhancement of rat kidney grafts.

Authors:  M E French; J R Batchelor
Journal:  Lancet       Date:  1969-11-22       Impact factor: 79.321

3.  Humoral antibodies in renal allotransplantation in man.

Authors:  M Jeannet; V W Pinn; M H Flax; H J Winn; P S Russell
Journal:  N Engl J Med       Date:  1970-01-15       Impact factor: 91.245

4.  Serotyping for homotransplantation. XII. Occurrence of cytotoxic antibodies following kidney transplantation in man.

Authors:  P J Morris; G M Williams; D M Hume; M R Mickey; P I Terasaki
Journal:  Transplantation       Date:  1968-05       Impact factor: 4.939

5.  Passive enhancement of neonatal skin grafts.

Authors:  R L Simmons; P S Russell
Journal:  Transplantation       Date:  1967-05       Impact factor: 4.939

6.  Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test.

Authors:  K K Mittal; M R Mickey; D P Singal; P I Terasaki
Journal:  Transplantation       Date:  1968-11       Impact factor: 4.939

7.  Specific immunosuppression by minute doses of passive antibody. II. The site of action.

Authors:  G Haughton; D O Adams
Journal:  J Reticuloendothel Soc       Date:  1970-04

8.  Studies on cellular immunity to human neuroblastoma cells.

Authors:  I Hellström; K E Hellström; A H Bill; G E Pierce; J P Yang
Journal:  Int J Cancer       Date:  1970-09-15       Impact factor: 7.396

9.  Antibody-mediated suppression of the immune response in vitro. I. Evidence for a central effect.

Authors:  M Feldmann; E Diener
Journal:  J Exp Med       Date:  1970-02       Impact factor: 14.307

10.  Phenotypic expressions of the major histocompatibility locus in man (HL-A): leukocyte antigens and mixed leukocyte culture reactivity.

Authors:  D B Amos; F H Bach
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

View more
  2 in total

1.  Rheumatoid factor and tumor-host interaction.

Authors:  J J Twomey; R D Rossen; V M Lewis; A H Laughter; C C Douglass
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

2.  Mixed leucocyte culture blocking factor activity in allograft recipients and its role in the clinical outcome of human cadaveric renal allografts.

Authors:  D P Sengar; A Rashid; J E Harris
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.